Back to companies
Inhibrx Biosciences, Inc.
INBXUSNASDAQPharmaceuticals & HealthcareInhibrx Biosciences, Inc.
Revenue
$1.3mn
YoY +550.0%
Operating income
-$135.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API